Home/Filings/4/0001694665-23-000009
4//SEC Filing

Thorell Marella 4

Accession 0001694665-23-000009

CIK 0001694665other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 4:25 PM ET

Size

5.4 KB

Accession

0001694665-23-000009

Insider Transaction Report

Form 4
Period: 2023-02-07
Thorell Marella
Chief Financial Officer
Transactions
  • Award

    Restricted Stock Units

    2023-02-07+520,000520,000 total
    Exercise: $0.00Common Stock (520,000 underlying)
Footnotes (1)
  • [F1]The Restricted Stock Units vest in four (4) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the first anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date.

Issuer

Evelo Biosciences, Inc.

CIK 0001694665

Entity typeother

Related Parties

1
  • filerCIK 0001826323

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:25 PM ET
Size
5.4 KB